Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Raltegravir Intensification in Discordant HIV Patients
2008-005473-35Phase 4Completed
- Sponsor
- Fight AIDS and Infectious Diseases Foundation
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of raltegravir in Human immunodeficiency virus infection type 1 and chronic human immunodeficiency virus infection (HIV), sponsored by Fight AIDS and Infectious Diseases Foundation. Primary endpoint: CD4 cell count. Started Sep 2008; status: completed.
02
Drugs
raltegravir
03
Conditions
Human immunodeficiency virus infection type 1chronic human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2008-005473-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005473-35.